About usOur mission Our team Partners FAQs

Medical newsLatest news Studies Interviews Testimonials

ProductsUEPM Onco UEPM Physicians

Terms and Conditions Privacy Policy

Terms and Conditions Privacy Policy

Terms and Conditions Privacy Policy

Last updated 19 days ago

A Research Study to Evaluate the Efficacy and Safety of Cenerimod in Subjects Suffering From Systemic Lupus Erythematosus

420 patients around the world

Available in Puerto Rico, Spain, United States, Chile

Idorsia Pharmaceuticals Ltd.

4Research sites

420Patients around the world

This study is for people with

Lupus

Systemic lupus erythematosus

Requirements for the patient

To 75 Years

All Gender

Medical requirements

Sites

Biomedica Research Group

Av. Salvador 149, piso 11, Providencia 7500710 - Santiago

Biomedica Research Group

Recruiting

Av. Salvador 149, piso 11, Providencia 7500710 - Santiago

Clinical Research Chile SpA

Beauchef 683, Valdivia, Los Ríos

Clinical Research Chile SpA

Recruiting

Beauchef 683, Valdivia, Los Ríos

Centro Reumatológico Caguas

Centro Reumatológico Caguas

Recruiting

Caguas, 00725

GCM Medical Group

San Juan, 00917

GCM Medical Group

Recruiting

San Juan, 00917

StudyOPUS-2

SponsorIdorsia Pharmaceuticals Ltd.

Conditions

Systemic lupus erythematosus

Requirements

To 75 YearsAll Gender

Unique study IDclinicaltrials.gov

NCT05672576

About usOur mission Our team Partners FAQs

Medical newsLatest news Studies Interviews Testimonials

ProductsUEPM Onco UEPM Physicians

Terms and Conditions

Terms and Conditions

Terms and Conditions